ArticleBreast cancer (Tokyo, Japan)2022

Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study.

Haruru Kotani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.